Beximco Delivers First Cut-Price Generic Paxlovid

Bangladesh’s Beximco signed off 2021 on a high launching the first generic version of Pfizer’s Paxlovid at about $186 for a five-day treatment course and claimed that it has ‘adequate capacities' for exports as well.

accelerate
Beximco launches first generic Paxlovid • Source: Alamy

Within days of the US Food and Drug Administration’s emergency use authorization for Pfizer Inc.’s Paxlovid (nirmatrelvir and ritonavir tablets, co-packaged for oral use), Bangladesh’s Beximco Pharmaceuticals Ltd. announced that it had rolled out the first cut-price generic of the oral pill for the treatment of mild-to-moderate COVID-19.

Rabbur Reza, Beximco Pharmaceuticals' chief operating officer, told Scrip that the company had developed the product (available as Bexovid) “on...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip